Amikacin prevents platelet aggregation in feline venous blood samples

© 2022 American Society for Veterinary Clinical Pathology.

Bibliographische Detailangaben
Veröffentlicht in:Veterinary clinical pathology. - 1975. - 51(2022), 1 vom: 07. März, Seite 51-56
1. Verfasser: Engelmann, Ana M (VerfasserIn)
Weitere Verfasser: Veleda, Patrícia A, Mello, Camila B E, Dutra, Lara S, Mann, Thaís R, Bueno, Andressa, Krause, Alexandre, de Andrade, Cinthia M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Veterinary clinical pathology
Schlagworte:Journal Article aminoglycoside domestic animals pseudothrombocytopenia venipuncture Amikacin 84319SGC3C Edetic Acid 9G34HU7RV0
LEADER 01000caa a22002652c 4500
001 NLM33674174X
003 DE-627
005 20250303003128.0
007 cr uuu---uuuuu
008 231225s2022 xx |||||o 00| ||eng c
024 7 |a 10.1111/vcp.13074  |2 doi 
028 5 2 |a pubmed25n1122.xml 
035 |a (DE-627)NLM33674174X 
035 |a (NLM)35141933 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Engelmann, Ana M  |e verfasserin  |4 aut 
245 1 0 |a Amikacin prevents platelet aggregation in feline venous blood samples 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 28.03.2022 
500 |a Date Revised 01.04.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2022 American Society for Veterinary Clinical Pathology. 
520 |a INTRODUCTION: Physiologically, feline platelets are more reactive and prone to aggregation, which interferes with platelet counts using automated counters and manual methods. The use of aminoglycoside amikacin in association with EDTA has proven to be efficient in preventing platelet aggregates in cases of pseudo thrombocytopenia (PTP) in people 
520 |a OBJECTIVES: This study evaluated the efficacy of amikacin in preventing platelet aggregation in EDTA-containing feline blood samples and investigated the possible effects on hematologic measurands 
520 |a MATERIALS AND METHODS: Blood samples (1.0 mL) collected from 100 healthy cats were stored in two EDTA tubes: 0.5 mL in a microtube containing 10 μL of 250 mg/mL amikacin (EDTA-AMK group) and 0.5 mL in a microtube containing only K2 EDTA 10% (EDTA group). A CBC was executed with an automated impedance blood analyzer, and a microscopic examination of the blood smears was performed 
520 |a RESULTS: Platelet clumps were observed in 56% of samples from the EDTA group and 5% of samples from the EDTA-AMK group. Platelet counts (PLT), plateletcrit (PCT), and WBC counts were significantly higher (P < .001) in the EDTA-AMK group compared withi the EDTA group 
520 |a CONCLUSIONS: Amikacin prevents platelet aggregation in feline venous blood samples and does not cause clinically relevant changes in other hematologic measurands. To our knowledge, this is the first report showing the use of amikacin in preventing platelet aggregation in feline blood samples. Based on this study, amikacin could be added to EDTA collection tubes for complete blood counts in cats 
650 4 |a Journal Article 
650 4 |a aminoglycoside 
650 4 |a domestic animals 
650 4 |a pseudothrombocytopenia 
650 4 |a venipuncture 
650 7 |a Amikacin  |2 NLM 
650 7 |a 84319SGC3C  |2 NLM 
650 7 |a Edetic Acid  |2 NLM 
650 7 |a 9G34HU7RV0  |2 NLM 
700 1 |a Veleda, Patrícia A  |e verfasserin  |4 aut 
700 1 |a Mello, Camila B E  |e verfasserin  |4 aut 
700 1 |a Dutra, Lara S  |e verfasserin  |4 aut 
700 1 |a Mann, Thaís R  |e verfasserin  |4 aut 
700 1 |a Bueno, Andressa  |e verfasserin  |4 aut 
700 1 |a Krause, Alexandre  |e verfasserin  |4 aut 
700 1 |a de Andrade, Cinthia M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Veterinary clinical pathology  |d 1975  |g 51(2022), 1 vom: 07. März, Seite 51-56  |w (DE-627)NLM098159984  |x 1939-165X  |7 nnas 
773 1 8 |g volume:51  |g year:2022  |g number:1  |g day:07  |g month:03  |g pages:51-56 
856 4 0 |u http://dx.doi.org/10.1111/vcp.13074  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 51  |j 2022  |e 1  |b 07  |c 03  |h 51-56